FDA Inspection 1022356 — Neotron S.p.A
The FDA completed an inspection of Neotron S.p.A on July 7, 2017 in Modena. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 7, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Modena (Italy)